ID   PPT1_HUMAN              Reviewed;         306 AA.
AC   P50897; B4DY24; Q6FGQ4;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Palmitoyl-protein thioesterase 1;
DE            Short=PPT-1;
DE            EC=3.1.2.22;
DE   AltName: Full=Palmitoyl-protein hydrolase 1;
DE   Flags: Precursor;
GN   Name=PPT1; Synonyms=CLN1 {ECO:0000303|PubMed:19941651}, PPT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND VARIANT CLN1
RP   TRP-122.
RC   TISSUE=Brain;
RX   PubMed=7637805; DOI=10.1038/376584a0;
RA   Vesa J., Hellsten E., Verkruyse L.A., Camp L.A., Rapola J.,
RA   Santavuori P., Hofmann S.L., Peltonen L.;
RT   "Mutations in the palmitoyl protein thioesterase gene causing
RT   infantile neuronal ceroid lipofuscinosis.";
RL   Nature 376:584-587(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8633062; DOI=10.1073/pnas.93.9.4316;
RA   Crews C.M., Lane W.S., Schreiber S.L.;
RT   "Didemnin binds to the protein palmitoyl thioesterase responsible for
RT   infantile neuronal ceroid lipofuscinosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:4316-4319(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8786130; DOI=10.1006/geno.1996.0292;
RA   Schriner J.E., Yi W., Hofmann S.L.;
RT   "cDNA and genomic cloning of human palmitoyl-protein thioesterase
RT   (PPT), the enzyme defective in infantile neuronal ceroid
RT   lipofuscinosis.";
RL   Genomics 34:317-322(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION.
RX   PubMed=8816748; DOI=10.1073/pnas.93.19.10046;
RA   Lu J.-Y., Verkruyse L.A., Hofmann S.L.;
RT   "Lipid thioesters derived from acylated proteins accumulate in
RT   infantile neuronal ceroid lipofuscinosis: correction of the defect in
RT   lymphoblasts by recombinant palmitoyl-protein thioesterase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:10046-10050(1996).
RN   [10]
RP   GLYCOSYLATION AT ASN-232.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-197; ASN-212 AND ASN-232.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   CLEAVAGE OF SIGNAL PEPTIDE [LARGE SCALE ANALYSIS] AFTER LEU-27, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.53 ANGSTROMS) OF 22-306, AND DISULFIDE BONDS.
RG   Structural genomics consortium (SGC);
RT   "Human palmitoyl-protein thioesterase 1.";
RL   Submitted (APR-2009) to the PDB data bank.
RN   [16]
RP   VARIANTS CLN1 PRO-75; GLY-79 AND GLN-219.
RX   PubMed=9425237; DOI=10.1093/hmg/7.2.291;
RA   Mitchison H.M., Hofmann S.L., Becerra C.H.R., Munroe P.B., Lake B.D.,
RA   Crow Y.J., Stephenson J.B.P., Williams R.E., Hofman I.L.,
RA   Taschner P.E.M., Martin J.-J., Philippart M., Andermann E.,
RA   Andermann F., Mole S.E., Gardiner R.M., O'Rawe A.M.;
RT   "Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1)
RT   causing juvenile neuronal ceroid lipofuscinosis with granular
RT   osmiophilic deposits.";
RL   Hum. Mol. Genet. 7:291-297(1998).
RN   [17]
RP   VARIANTS CLN1, AND VARIANT THR-134.
RX   PubMed=9664077; DOI=10.1172/JCI3112;
RA   Das A.K., Becerra C.H.R., Yi W., Lu J.-Y., Siakotos A.N.,
RA   Wisniewski K.E., Hofmann S.L.;
RT   "Molecular genetics of palmitoyl-protein thioesterase deficiency in
RT   the U.S.";
RL   J. Clin. Invest. 102:361-370(1998).
RN   [18]
RP   VARIANT CLN1 ARG-108.
RX   PubMed=11506414; DOI=10.1002/ana.1103;
RA   van Diggelen O.P., Thobois S., Tilikete C., Zabot M.-T.,
RA   Keulemans J.L.M., van Bunderen P.A., Taschner P.E.M., Losekoot M.,
RA   Voznyi Y.V.;
RT   "Adult neuronal ceroid lipofuscinosis with palmitoyl-protein
RT   thioesterase deficiency: first adult-onset patients of a childhood
RT   disease.";
RL   Ann. Neurol. 50:269-272(2001).
RN   [19]
RP   CHARACTERIZATION OF VARIANTS CLN1 ARG-108 AND TRP-122, INTERACTION
RP   WITH CLN5, AND SUBCELLULAR LOCATION.
RX   PubMed=19941651; DOI=10.1186/1471-2121-10-83;
RA   Lyly A., von Schantz C., Heine C., Schmiedt M.L., Sipilae T.,
RA   Jalanko A., Kyttaelae A.;
RT   "Novel interactions of CLN5 support molecular networking between
RT   neuronal ceroid lipofuscinosis proteins.";
RL   BMC Cell Biol. 10:83-83(2009).
RN   [20]
RP   VARIANT CLN1 CYS-38.
RX   PubMed=19201763; DOI=10.1093/brain/awn366;
RA   Kousi M., Siintola E., Dvorakova L., Vlaskova H., Turnbull J.,
RA   Topcu M., Yuksel D., Gokben S., Minassian B.A., Elleder M., Mole S.E.,
RA   Lehesjoki A.-E.;
RT   "Mutations in CLN7/MFSD8 are a common cause of variant late-infantile
RT   neuronal ceroid lipofuscinosis.";
RL   Brain 132:810-819(2009).
RN   [21]
RP   VARIANTS CLN1 TYR-45; PRO-75; GLY-79; ARG-108; ASP-109; LEU-138;
RP   TYR-152; GLU-177; MET-181; ARG-187; ARG-189; GLN-219; PRO-222;
RP   GLY-228; HIS-247; VAL-250; ARG-296 AND PRO-305.
RX   PubMed=21990111; DOI=10.1002/humu.21624;
RA   Kousi M., Lehesjoki A.E., Mole S.E.;
RT   "Update of the mutation spectrum and clinical correlations of over 360
RT   mutations in eight genes that underlie the neuronal ceroid
RT   lipofuscinoses.";
RL   Hum. Mutat. 33:42-63(2012).
CC   -!- FUNCTION: Removes thioester-linked fatty acyl groups such as
CC       palmitate from modified cysteine residues in proteins or peptides
CC       during lysosomal degradation. Prefers acyl chain lengths of 14 to
CC       18 carbons (PubMed:8816748). {ECO:0000269|PubMed:8816748}.
CC   -!- CATALYTIC ACTIVITY: Palmitoyl-[protein] + H(2)O = palmitate +
CC       [protein]. {ECO:0000250|UniProtKB:P45478}.
CC   -!- SUBUNIT: Interacts with CLN5 (PubMed:19941651). Interacts with
CC       ATP5A1 and ATP5B (By similarity). {ECO:0000250|UniProtKB:O88531,
CC       ECO:0000269|PubMed:19941651}.
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:19941651}.
CC       Secreted {ECO:0000250|UniProtKB:P45478}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P50897-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50897-2; Sequence=VSP_042033;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:P45478}.
CC   -!- DISEASE: Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]: A
CC       form of neuronal ceroid lipofuscinosis with variable age at onset.
CC       Infantile, late-infantile, juvenile, and adult onset have been
CC       reported. Neuronal ceroid lipofuscinoses are progressive
CC       neurodegenerative, lysosomal storage diseases characterized by
CC       intracellular accumulation of autofluorescent liposomal material,
CC       and clinically by seizures, dementia, visual loss, and/or cerebral
CC       atrophy. The lipopigment pattern seen most often in CLN1 is
CC       referred to as granular osmiophilic deposits (GROD).
CC       {ECO:0000269|PubMed:11506414, ECO:0000269|PubMed:19201763,
CC       ECO:0000269|PubMed:19941651, ECO:0000269|PubMed:21990111,
CC       ECO:0000269|PubMed:7637805, ECO:0000269|PubMed:9425237,
CC       ECO:0000269|PubMed:9664077}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the palmitoyl-protein thioesterase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NCL CLN1; Note=Neural Ceroid Lipofuscinoses
CC       mutation db;
CC       URL="http://www.ucl.ac.uk/ncl/cln1.shtml";
CC   -!- WEB RESOURCE: Name=Mutations of the PPT1 gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/pptmut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42809; AAA85337.1; -; Genomic_DNA.
DR   EMBL; U44772; AAB06236.1; -; mRNA.
DR   EMBL; AF022211; AAB72224.1; -; Genomic_DNA.
DR   EMBL; AF022203; AAB72224.1; JOINED; Genomic_DNA.
DR   EMBL; AF022204; AAB72224.1; JOINED; Genomic_DNA.
DR   EMBL; AF022205; AAB72224.1; JOINED; Genomic_DNA.
DR   EMBL; AF022206; AAB72224.1; JOINED; Genomic_DNA.
DR   EMBL; AF022207; AAB72224.1; JOINED; Genomic_DNA.
DR   EMBL; AF022208; AAB72224.1; JOINED; Genomic_DNA.
DR   EMBL; AF022209; AAB72224.1; JOINED; Genomic_DNA.
DR   EMBL; AF022210; AAB72224.1; JOINED; Genomic_DNA.
DR   EMBL; AK302232; BAG63586.1; -; mRNA.
DR   EMBL; AK312287; BAG35214.1; -; mRNA.
DR   EMBL; CR542053; CAG46850.1; -; mRNA.
DR   EMBL; AL512599; CAI11025.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07237.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07238.1; -; Genomic_DNA.
DR   EMBL; BC008426; AAH08426.1; -; mRNA.
DR   CCDS; CCDS44119.1; -. [P50897-2]
DR   CCDS; CCDS447.1; -. [P50897-1]
DR   PIR; I58097; I58097.
DR   RefSeq; NP_000301.1; NM_000310.3. [P50897-1]
DR   RefSeq; NP_001136076.1; NM_001142604.1. [P50897-2]
DR   UniGene; Hs.3873; -.
DR   PDB; 3GRO; X-ray; 2.53 A; A/B=22-306.
DR   PDBsum; 3GRO; -.
DR   ProteinModelPortal; P50897; -.
DR   SMR; P50897; -.
DR   BioGrid; 111530; 37.
DR   IntAct; P50897; 9.
DR   MINT; MINT-3018663; -.
DR   STRING; 9606.ENSP00000394863; -.
DR   BindingDB; P50897; -.
DR   ChEMBL; CHEMBL2331051; -.
DR   DrugBank; DB02035; 1-Hexadecylsulfonyl Fluoride.
DR   DrugBank; DB03796; Palmitic Acid.
DR   ESTHER; human-PPT1; Palmitoyl-protein_thioesterase.
DR   iPTMnet; P50897; -.
DR   PhosphoSitePlus; P50897; -.
DR   SwissPalm; P50897; -.
DR   BioMuta; PPT1; -.
DR   DMDM; 1709747; -.
DR   EPD; P50897; -.
DR   PaxDb; P50897; -.
DR   PeptideAtlas; P50897; -.
DR   PRIDE; P50897; -.
DR   DNASU; 5538; -.
DR   Ensembl; ENST00000433473; ENSP00000394863; ENSG00000131238. [P50897-1]
DR   Ensembl; ENST00000449045; ENSP00000392293; ENSG00000131238. [P50897-2]
DR   Ensembl; ENST00000529905; ENSP00000432053; ENSG00000131238. [P50897-1]
DR   GeneID; 5538; -.
DR   KEGG; hsa:5538; -.
DR   UCSC; uc001cfb.3; human. [P50897-1]
DR   CTD; 5538; -.
DR   DisGeNET; 5538; -.
DR   GeneCards; PPT1; -.
DR   GeneReviews; PPT1; -.
DR   HGNC; HGNC:9325; PPT1.
DR   HPA; HPA021546; -.
DR   MalaCards; PPT1; -.
DR   MIM; 256730; phenotype.
DR   MIM; 600722; gene.
DR   neXtProt; NX_P50897; -.
DR   OpenTargets; ENSG00000131238; -.
DR   Orphanet; 228329; CLN1 disease.
DR   PharmGKB; PA33688; -.
DR   eggNOG; KOG2541; Eukaryota.
DR   eggNOG; COG1075; LUCA.
DR   GeneTree; ENSGT00530000063368; -.
DR   HOGENOM; HOG000199232; -.
DR   HOVERGEN; HBG018186; -.
DR   InParanoid; P50897; -.
DR   KO; K01074; -.
DR   OMA; LQETTLY; -.
DR   OrthoDB; EOG091G0HJH; -.
DR   PhylomeDB; P50897; -.
DR   TreeFam; TF323926; -.
DR   BRENDA; 3.1.2.2; 2681.
DR   BRENDA; 3.1.2.22; 2681.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   ChiTaRS; PPT1; human.
DR   EvolutionaryTrace; P50897; -.
DR   GeneWiki; PPT1; -.
DR   GenomeRNAi; 5538; -.
DR   PRO; PR:P50897; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000131238; -.
DR   CleanEx; HS_PPT1; -.
DR   ExpressionAtlas; P50897; baseline and differential.
DR   Genevisible; P50897; HS.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:UniProtKB.
DR   GO; GO:0008474; F:palmitoyl-(protein) hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0016290; F:palmitoyl-CoA hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0008306; P:associative learning; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IMP:UniProtKB.
DR   GO; GO:0044257; P:cellular protein catabolic process; IEA:Ensembl.
DR   GO; GO:0051186; P:cofactor metabolic process; IMP:UniProtKB.
DR   GO; GO:0051181; P:cofactor transport; IMP:UniProtKB.
DR   GO; GO:0007625; P:grooming behavior; IEA:Ensembl.
DR   GO; GO:0016042; P:lipid catabolic process; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0007042; P:lysosomal lumen acidification; IMP:UniProtKB.
DR   GO; GO:0031579; P:membrane raft organization; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IMP:UniProtKB.
DR   GO; GO:0048666; P:neuron development; TAS:UniProtKB.
DR   GO; GO:0007269; P:neurotransmitter secretion; IEA:Ensembl.
DR   GO; GO:0006907; P:pinocytosis; IMP:MGI.
DR   GO; GO:0048549; P:positive regulation of pinocytosis; IMP:UniProtKB.
DR   GO; GO:0048260; P:positive regulation of receptor-mediated endocytosis; IMP:UniProtKB.
DR   GO; GO:0030163; P:protein catabolic process; NAS:UniProtKB.
DR   GO; GO:0002084; P:protein depalmitoylation; IDA:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IMP:UniProtKB.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IMP:MGI.
DR   GO; GO:0032429; P:regulation of phospholipase A2 activity; IEA:Ensembl.
DR   GO; GO:0050803; P:regulation of synapse structure or activity; NAS:UniProtKB.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0030149; P:sphingolipid catabolic process; TAS:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002472; Palm_thioest.
DR   InterPro; IPR030294; PPT1.
DR   PANTHER; PTHR11247:SF36; PTHR11247:SF36; 1.
DR   Pfam; PF02089; Palm_thioest; 1.
DR   PRINTS; PR00414; PPTHIESTRASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Disease mutation; Disulfide bond; Glycoprotein; Hydrolase; Lysosome;
KW   Neurodegeneration; Neuronal ceroid lipofuscinosis; Polymorphism;
KW   Reference proteome; Secreted; Sensory transduction; Signal; Vision.
FT   SIGNAL        1     27       {ECO:0000244|PubMed:25944712}.
FT   CHAIN        28    306       Palmitoyl-protein thioesterase 1.
FT                                /FTId=PRO_0000025550.
FT   ACT_SITE    115    115       {ECO:0000250|UniProtKB:P45478}.
FT   ACT_SITE    233    233       {ECO:0000250|UniProtKB:P45478}.
FT   ACT_SITE    289    289       {ECO:0000250|UniProtKB:P45478}.
FT   CARBOHYD    197    197       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    212    212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    232    232       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218}.
FT   DISULFID     45     46       {ECO:0000269|Ref.15}.
FT   DISULFID     96    128       {ECO:0000269|Ref.15}.
FT   DISULFID    152    160       {ECO:0000269|Ref.15}.
FT   VAR_SEQ      42    144       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042033.
FT   VARIANT      38     38       W -> C (in CLN1; dbSNP:rs386833626).
FT                                {ECO:0000269|PubMed:19201763}.
FT                                /FTId=VAR_058434.
FT   VARIANT      39     39       H -> Q (in CLN1; dbSNP:rs386833627).
FT                                /FTId=VAR_005548.
FT   VARIANT      42     42       G -> E (in CLN1; dbSNP:rs386833631).
FT                                /FTId=VAR_005549.
FT   VARIANT      45     45       C -> Y (in CLN1; dbSNP:rs137852702).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_066874.
FT   VARIANT      75     75       T -> P (in CLN1; juvenile onset;
FT                                dbSNP:rs137852696).
FT                                {ECO:0000269|PubMed:21990111,
FT                                ECO:0000269|PubMed:9425237}.
FT                                /FTId=VAR_005550.
FT   VARIANT      79     79       D -> G (in CLN1; juvenile onset;
FT                                dbSNP:rs137852697).
FT                                {ECO:0000269|PubMed:21990111,
FT                                ECO:0000269|PubMed:9425237}.
FT                                /FTId=VAR_005551.
FT   VARIANT     108    108       G -> R (in CLN1; onset in adulthood;
FT                                retained in the endoplasmic reticulum
FT                                rather than reaching the lysosome;
FT                                dbSNP:rs137852701).
FT                                {ECO:0000269|PubMed:11506414,
FT                                ECO:0000269|PubMed:19941651,
FT                                ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_018511.
FT   VARIANT     109    109       Y -> D (in CLN1; late infantile form;
FT                                dbSNP:rs386833642).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_005552.
FT   VARIANT     122    122       R -> W (in CLN1; retained in the
FT                                endoplasmic reticulum rather than
FT                                reaching the lysosome;
FT                                dbSNP:rs137852695).
FT                                {ECO:0000269|PubMed:19941651,
FT                                ECO:0000269|PubMed:7637805}.
FT                                /FTId=VAR_005553.
FT   VARIANT     134    134       I -> T (in dbSNP:rs1800205).
FT                                {ECO:0000269|PubMed:9664077}.
FT                                /FTId=VAR_005554.
FT   VARIANT     138    138       S -> L (in CLN1; dbSNP:rs386833646).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_066875.
FT   VARIANT     152    152       C -> Y (in CLN1; dbSNP:rs386833647).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_066876.
FT   VARIANT     177    177       Q -> E (in CLN1; late infantile form;
FT                                dbSNP:rs386833650).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_005555.
FT   VARIANT     181    181       V -> L (in CLN1; dbSNP:rs148412181).
FT                                /FTId=VAR_005556.
FT   VARIANT     181    181       V -> M (in CLN1; late infantile form;
FT                                dbSNP:rs148412181).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_005557.
FT   VARIANT     187    187       H -> R (in CLN1; dbSNP:rs386833657).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_066877.
FT   VARIANT     189    189       P -> R (in CLN1; dbSNP:rs386833658).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_066878.
FT   VARIANT     219    219       L -> Q (in CLN1; juvenile onset;
FT                                dbSNP:rs137852698).
FT                                {ECO:0000269|PubMed:21990111,
FT                                ECO:0000269|PubMed:9425237}.
FT                                /FTId=VAR_005558.
FT   VARIANT     222    222       L -> P (in CLN1; late infantile form;
FT                                dbSNP:rs386833661).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_066879.
FT   VARIANT     228    228       V -> G (in CLN1; dbSNP:rs386833663).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_066880.
FT   VARIANT     247    247       Y -> H (in CLN1; dbSNP:rs386833665).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_005559.
FT   VARIANT     250    250       G -> V (in CLN1; dbSNP:rs386833666).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_005560.
FT   VARIANT     296    296       W -> R (in CLN1; dbSNP:rs386833669).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_066881.
FT   VARIANT     305    305       L -> P (in CLN1; dbSNP:rs386833671).
FT                                {ECO:0000269|PubMed:21990111}.
FT                                /FTId=VAR_066882.
FT   STRAND       35     38       {ECO:0000244|PDB:3GRO}.
FT   TURN         48     50       {ECO:0000244|PDB:3GRO}.
FT   HELIX        51     61       {ECO:0000244|PDB:3GRO}.
FT   STRAND       67     69       {ECO:0000244|PDB:3GRO}.
FT   STRAND       73     75       {ECO:0000244|PDB:3GRO}.
FT   HELIX        76     85       {ECO:0000244|PDB:3GRO}.
FT   HELIX        88    101       {ECO:0000244|PDB:3GRO}.
FT   HELIX       103    105       {ECO:0000244|PDB:3GRO}.
FT   STRAND      109    114       {ECO:0000244|PDB:3GRO}.
FT   HELIX       116    127       {ECO:0000244|PDB:3GRO}.
FT   STRAND      133    140       {ECO:0000244|PDB:3GRO}.
FT   STRAND      153    155       {ECO:0000244|PDB:3GRO}.
FT   HELIX       157    170       {ECO:0000244|PDB:3GRO}.
FT   HELIX       174    177       {ECO:0000244|PDB:3GRO}.
FT   HELIX       181    185       {ECO:0000244|PDB:3GRO}.
FT   STRAND      189    191       {ECO:0000244|PDB:3GRO}.
FT   HELIX       192    198       {ECO:0000244|PDB:3GRO}.
FT   HELIX       202    205       {ECO:0000244|PDB:3GRO}.
FT   STRAND      208    210       {ECO:0000244|PDB:3GRO}.
FT   HELIX       213    220       {ECO:0000244|PDB:3GRO}.
FT   STRAND      223    230       {ECO:0000244|PDB:3GRO}.
FT   STRAND      234    238       {ECO:0000244|PDB:3GRO}.
FT   HELIX       239    243       {ECO:0000244|PDB:3GRO}.
FT   HELIX       258    260       {ECO:0000244|PDB:3GRO}.
FT   HELIX       262    265       {ECO:0000244|PDB:3GRO}.
FT   STRAND      268    270       {ECO:0000244|PDB:3GRO}.
FT   HELIX       271    276       {ECO:0000244|PDB:3GRO}.
FT   STRAND      280    288       {ECO:0000244|PDB:3GRO}.
FT   HELIX       294    300       {ECO:0000244|PDB:3GRO}.
FT   HELIX       302    305       {ECO:0000244|PDB:3GRO}.
SQ   SEQUENCE   306 AA;  34193 MW;  69F8083FD1C15E92 CRC64;
     MASPGCLWLL AVALLPWTCA SRALQHLDPP APLPLVIWHG MGDSCCNPLS MGAIKKMVEK
     KIPGIYVLSL EIGKTLMEDV ENSFFLNVNS QVTTVCQALA KDPKLQQGYN AMGFSQGGQF
     LRAVAQRCPS PPMINLISVG GQHQGVFGLP RCPGESSHIC DFIRKTLNAG AYSKVVQERL
     VQAEYWHDPI KEDVYRNHSI FLADINQERG INESYKKNLM ALKKFVMVKF LNDSIVDPVD
     SEWFGFYRSG QAKETIPLQE TSLYTQDRLG LKEMDNAGQL VFLATEGDHL QLSEEWFYAH
     IIPFLG
//
